These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8387123)

  • 1. Modification by cGMP of glibenclamide-sensitive K+ currents in Xenopus oocytes.
    Sakuta H; Okamoto K; Watanabe Y
    Jpn J Pharmacol; 1993 Mar; 61(3):259-62. PubMed ID: 8387123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological interaction experiments differentiate between glibenclamide-sensitive K+ channels and cyclic GMP as components of vasodilation by nicorandil.
    Holzmann S; Kukovetz WR; Braida C; Pöch G
    Eur J Pharmacol; 1992 Apr; 215(1):1-7. PubMed ID: 1325362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation by KRN2391 and nicorandil of glibenclamide-sensitive K+ channels in Xenopus oocytes.
    Sakuta H; Okamoto K
    Eur J Pharmacol; 1993 Feb; 244(3):277-83. PubMed ID: 8458402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicorandil activates glibenclamide-sensitive K+ channels in smooth muscle cells of pig proximal urethra.
    Teramoto N; Brading AF
    J Pharmacol Exp Ther; 1997 Jan; 280(1):483-91. PubMed ID: 8996232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of relaxation and repolarization mechanisms of nicorandil in rat mesenteric artery.
    Fujiwara T; Angus JA
    Br J Pharmacol; 1996 Dec; 119(8):1549-56. PubMed ID: 8982500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissimilarity in the mechanisms of action of KRN2391, nicorandil and cromakalim in canine renal artery.
    Kasai H; Fukata Y; Harada K; Fukushima H; Ogawa N
    J Pharm Pharmacol; 1993 Mar; 45(3):222-4. PubMed ID: 8097782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The vasospasmolytic effects of nicorandil, cromakalim and pinacidil on 3,4-diaminopyridine-induced phasic contractions in canine coronary arteries as an experimental vasospasm model].
    Kamijo T; Tomaru T; Miwa A; Nakamura F; Kido H; Sugimoto T; Uchida Y
    Nihon Yakurigaku Zasshi; 1992 Oct; 100(4):317-27. PubMed ID: 1446882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of nicorandil by 86Rb efflux and isometric vasorelaxation studies in vascular smooth muscle.
    Kreye VA; Lenz T; Pfründer D; Theiss U
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S8-12. PubMed ID: 1282181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicorandil as a nitrate, and cromakalim as a potassium channel opener, dilate isolated porcine large coronary arteries in an agonist-nonselective manner.
    Satoh K; Mori T; Yamada H; Taira N
    Cardiovasc Drugs Ther; 1993 Aug; 7(4):691-9. PubMed ID: 8241013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition by histamine H1 receptor antagonists of endogenous glibenclamide-sensitive K+ channels in follicle-enclosed Xenopus oocytes.
    Sakuta H
    Eur J Pharmacol; 1994 Jan; 266(1):99-102. PubMed ID: 7907990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial natriuretic factor potentiates glibenclamide-sensitive K+ currents via the activation of receptor guanylate cyclase in follicle-enclosed Xenopus oocytes.
    Sakuta H; Okamoto K; Tandai M
    Eur J Pharmacol; 1994 May; 267(3):281-7. PubMed ID: 7916303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ATP-sensitive K+ channel openers on pacemaker activity in isolated single rabbit sino-atrial node cells.
    Satoh H
    J Cardiovasc Pharmacol; 1993 Dec; 22(6):863-8. PubMed ID: 7509906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of KRN2391, a novel vasodilator, in canine mesenteric artery.
    Ogawa N; Fukata Y; Kaneta S; Jinno Y; Miwa A; Fukushima H
    Jpn J Pharmacol; 1993 Apr; 61(4):303-9. PubMed ID: 8320876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action of KRN2391 in canine coronary vascular bed.
    Fukata Y; Kaneta S; Okada Y; Yokoyama T; Jinno Y; Fukushima H; Ogawa N
    Jpn J Pharmacol; 1993 Nov; 63(3):305-11. PubMed ID: 8107323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanism of action of nicorandil.
    Kukovetz WR; Holzmann S; Pöch G
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S1-7. PubMed ID: 1282168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two different types of channels are targets for potassium channel openers in Xenopus oocytes.
    Honoré E; Lazdunski M
    FEBS Lett; 1991 Aug; 287(1-2):75-9. PubMed ID: 1908792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of glibenclamide-sensitive K+ channels in Xenopus oocytes by various calmodulin antagonists.
    Sakuta H; Sekiguchi M; Okamoto K; Sakai Y
    Eur J Pharmacol; 1992 Jul; 226(3):199-207. PubMed ID: 1330630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dualistic mode of action of the vasodilator drug, nicorandil, differentiated by glibenclamide in 86Rb flux studies in rabbit isolated vascular smooth muscle.
    Kreye VA; Lenz T; Theiss U
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):70-5. PubMed ID: 1827659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasorelaxant mechanism of KRN2391 and nicorandil in porcine coronary arteries of different sizes.
    Miwa A; Kaneta S; Motoki K; Jinno Y; Kasai H; Okada Y; Fukushima H; Ogawa N
    Br J Pharmacol; 1993 Jul; 109(3):632-6. PubMed ID: 8358563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glibenclamide is a competitive antagonist of cromakalim, pinacidil and RP 49356 in guinea-pig pulmonary artery.
    Eltze M
    Eur J Pharmacol; 1989 Jun; 165(2-3):231-9. PubMed ID: 2528466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.